Skip to main content
VCbacked
Log inGet Started

Hydrocision

North Billerica, United States

HydroCision develops, manufactures, and markets fluid jet-based surgical tools for minimally invasive spine surgery requirements.

$2.5M raised
Apr 2025
Venture - Series Unknown
Health CareHealth DiagnosticsManufacturingMedicalMedical Device

Top Investors

Omega FundsBioventures InvestorsOxford Bioscience PartnersVolcano CapitalNewbury Ventures

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Hydrocision

How much funding has Hydrocision raised?
Hydrocision has raised $2.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2025.
Who are Hydrocision's investors?
Hydrocision's investors include Omega Funds, Bioventures Investors, Oxford Bioscience Partners, Volcano Capital, Newbury Ventures.
Where is Hydrocision headquartered?
Hydrocision is headquartered in North Billerica, United States.
What does Hydrocision do?
HydroCision develops, manufactures, and markets fluid jet-based surgical tools for minimally invasive spine surgery requirements.
What stage is Hydrocision at?
Hydrocision is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Hydrocision — Funding & Investors." VCBacked, April 1, 2025, https://www.vcbacked.co/company/hydrocision. Accessed June 8, 2026.
APA
VCBacked. (2025). Hydrocision — Funding & Investors. Retrieved June 8, 2026, from https://www.vcbacked.co/company/hydrocision
Wikipedia (cite web)
{{cite web |title=Hydrocision — Funding & Investors |url=https://www.vcbacked.co/company/hydrocision |website=VCBacked |access-date=June 8, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Health Care

View all
Virtuoso Surgical
Nashville
Basata
Phoenix
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Sedivention
Munich$848K